Figure 5. Kaplan-Meier survival analyses on differential PLOD1/2/3 expression groups with PFS. (A–C) and OS (D–F) in the included 533 ccRCC patients. Compared with low mRNA expression of PLODs, high PLOD1 expressions were significantly correlated with poor PFS (p=0.002) and OS (p<0.001), high PLOD2 expressions were significantly associated with poor PFS (p=0.001) and OS (p<0.001), and elevated PLOD3 expressions were significantly correlated with shorter PFS (p=0.018) and OS (p<0.001).